GeneThera Inc
GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of zoonotic diseases. It offers treatments for zoonotic diseases, such as COVID -19 disease; paratuberculosis (Johne's disease) that is in Stage III clinical phase; mad cow and chronic wasting diseases; and E.coli and salmonella infections, as well as develops vaccine for mycobacte… Read more
Market Cap & Net Worth: GeneThera Inc (GTHR)
GeneThera Inc (PINK:GTHR) has a market capitalization of $3.53K ($3.53K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #46754 globally and #14541 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GeneThera Inc's stock price $0.00 by its total outstanding shares 35333300 (35.33 Million).
GeneThera Inc Market Cap History: 2015 to 2024
GeneThera Inc's market capitalization history from 2015 to 2024. Data shows change from $1.10 Million to $3.53K (-50.42% CAGR).
GeneThera Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GeneThera Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of GTHR by Market Capitalization
Companies near GeneThera Inc in the global market cap rankings as of March 18, 2026.
Key companies related to GeneThera Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #158 globally with a market cap of $118.01 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.58 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #158 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $118.01 Billion | $466.10 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.58 Billion | $756.91 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
GeneThera Inc Historical Marketcap From 2015 to 2024
Between 2015 and today, GeneThera Inc's market cap moved from $1.10 Million to $ 3.53K, with a yearly change of -50.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $3.53K | -98.33% |
| 2023 | $212.00K | -1.64% |
| 2022 | $215.53K | -81.06% |
| 2021 | $1.14 Million | +126.76% |
| 2020 | $501.73K | +102.86% |
| 2019 | $247.33K | -15.66% |
| 2018 | $293.27K | -17.00% |
| 2017 | $353.33K | -33.33% |
| 2016 | $530.00K | -51.61% |
| 2015 | $1.10 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 28th, 2025 the market cap of GeneThera Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.53K USD |
| MoneyControl | $3.53K USD |
| MarketWatch | $3.53K USD |
| marketcap.company | $3.53K USD |
| Reuters | $3.53K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.